Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shuko Takeda

Showing results (31-40 of 66) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2010
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetesShuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, et al.
Biochemical and Biophysical Research Communications|May 20, 2009
Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse modelsShuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, et al.
AJNR. American Journal of Neuroradiology|February 8, 2024
Imaging Biomarker for Early-Stage Alzheimer Disease: Utility of Hippocampal Histogram Analysis of Diffusion MetricsHiroto Takahashi, Yoichi Takami, Shuko Takeda, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in MiceTomohiro Kawano, Munehisa Shimamura, Hironori Nakagami, et al.
Brain Research|March 12, 2026
A fully automated immunoassay for plasma kallikrein-8: Development and evaluation in mild cognitive impairmentIshita Gupta, Masahiro Miura, Ayaka Kimura, et al.
The Journal of Biological Chemistry|December 4, 2014
A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer diseaseYukiko Hori, Shuko Takeda, Hansang Cho, et al.
Dementia and Geriatric Cognitive Disorders|March 6, 2023
Antiepileptic Drugs Modulate Alzheimer-Related Tau Aggregation in a Neuronal Activity-Independent MannerYuki Ito, Shuko Takeda, Sayaka Moroi, et al.
Fluids and Barriers of the CNS|May 3, 2022
A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving miceTsuneo Nakajima, Shuko Takeda, Yuki Ito, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 20, 2022
Novel pathophysiological roles of α-synuclein in age-related vascular endothelial dysfunctionYoichi Takami, Cheng Wang, Hironori Nakagami, et al.
Scientific Reports|September 12, 2019
Novel Method for Rapid Assessment of Cognitive Impairment Using High-Performance Eye-Tracking TechnologyAkane Oyama, Shuko Takeda, Yuki Ito, et al.
Pageof 7

Showing results (31-40 of 66) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|March 17, 2010
Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Abeta deposition in an Alzheimer mouse model with diabetesShuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, et al.
Biochemical and Biophysical Research Communications|May 20, 2009
Elevation of plasma beta-amyloid level by glucose loading in Alzheimer mouse modelsShuko Takeda, Naoyuki Sato, Kozue Uchio-Yamada, et al.
AJNR. American Journal of Neuroradiology|February 8, 2024
Imaging Biomarker for Early-Stage Alzheimer Disease: Utility of Hippocampal Histogram Analysis of Diffusion MetricsHiroto Takahashi, Yoichi Takami, Shuko Takeda, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2018
Therapeutic Vaccine Against S100A9 (S100 Calcium-Binding Protein A9) Inhibits Thrombosis Without Increasing the Risk of Bleeding in Ischemic Stroke in MiceTomohiro Kawano, Munehisa Shimamura, Hironori Nakagami, et al.
Brain Research|March 12, 2026
A fully automated immunoassay for plasma kallikrein-8: Development and evaluation in mild cognitive impairmentIshita Gupta, Masahiro Miura, Ayaka Kimura, et al.
The Journal of Biological Chemistry|December 4, 2014
A Food and Drug Administration-approved asthma therapeutic agent impacts amyloid β in the brain in a transgenic model of Alzheimer diseaseYukiko Hori, Shuko Takeda, Hansang Cho, et al.
Dementia and Geriatric Cognitive Disorders|March 6, 2023
Antiepileptic Drugs Modulate Alzheimer-Related Tau Aggregation in a Neuronal Activity-Independent MannerYuki Ito, Shuko Takeda, Sayaka Moroi, et al.
Fluids and Barriers of the CNS|May 3, 2022
A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving miceTsuneo Nakajima, Shuko Takeda, Yuki Ito, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 20, 2022
Novel pathophysiological roles of α-synuclein in age-related vascular endothelial dysfunctionYoichi Takami, Cheng Wang, Hironori Nakagami, et al.
Scientific Reports|September 12, 2019
Novel Method for Rapid Assessment of Cognitive Impairment Using High-Performance Eye-Tracking TechnologyAkane Oyama, Shuko Takeda, Yuki Ito, et al.
Pageof 7